UK markets closed

Evelo Biosciences, Inc. (EVLO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0495+0.0076 (+18.14%)
As of 09:30AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-119,638
-114,527
-122,176
-93,666
Depreciation & amortisation
2,075
2,060
2,216
2,026
Stock-based compensation
16,106
15,158
15,846
8,468
Change in working capital
-8,545
-9,666
2,068
7,765
Accounts payable
-956
170
159
837
Other working capital
-105,842
-101,857
-98,244
-74,384
Other non-cash items
2,879
4,386
2,102
2,350
Net cash provided by operating activities
-105,891
-101,235
-96,725
-73,063
Cash flows from investing activities
Investments in property, plant and equipment
49
-622
-1,519
-1,321
Sales/maturities of investments
-
-
-
0
Net cash used for investing activities
81
-622
-1,481
-1,315
Cash flows from financing activities
Debt repayment
-52,659
-47,610
0
0
Common stock issued
79,472
84,544
81,751
54,994
Net cash used provided by (used for) financing activities
79,790
81,655
97,540
65,465
Net change in cash
-27,042
-20,656
-666
-8,913
Cash at beginning of period
97,251
69,754
70,420
79,333
Cash at end of period
71,231
49,098
69,754
70,420
Free cash flow
Operating cash flow
-105,891
-101,235
-96,725
-73,063
Capital expenditure
49
-622
-1,519
-1,321
Free cash flow
-105,842
-101,857
-98,244
-74,384